|
|||||
|
|
Post-marketing safety monitoring of a new group B meningococcal vaccine in New Zealand, 2004-2006 |
|
| Authors: | McNicholas Anne Galloway Yvonne Stehr-Green Paul Reid Stewart Radke Sarah Sexton Kerry Kieft Charlotte Macdonald Claire Neutze Jocelyn Drake Ross Isaac Dorothy O'Donnell Mary Tatley Michael Oster Philipp O'Hallahan Jane |
| Institution: | Meningococcal Vaccine Strategy, Ministry of Health, Wellington, New Zealand. anne_mcnicholas@moh.govt.nz |
| Abstract: | New Zealand introduced a new outer membrane vesicle vaccine in 2004 to combat an epidemic of group B meningococcal disease. An Independent Safety Monitoring Board oversaw intensive safety monitoring, which included hospital surveillance, health professional reporting (passive and active) and mortality monitoring. With over three million doses administered to individuals aged under 20 years, the monitoring results provide consistent evidence supporting the vaccine's safety. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |